Vimarsana
Biggest News Aggregation in the World

Page 45 - Olely News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Olely. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Olely Today - Breaking & Trending Today

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten - Vimarsana News

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten

Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to

Edisun Power Europe AG: Edisun Power focuses on large-scale Solar plants - adhoc - Börsennachrichten - Vimarsana News

Edisun Power Europe AG: Edisun Power focuses on large-scale Solar plants - adhoc - Börsennachrichten

Edisun Power Europe AG Key word Strategic Company Decision Edisun Power Europe AG Edisun Power focuses on largescale Solar plants 27Dec2023 2315 CETCEST Release of an ad hoc announcement pursuant to

EQS-Adhoc: Enapter AG: Ad-Hoc Captain America - EBITDA - adhoc - Börsennachrichten - Vimarsana News

EQS-Adhoc: Enapter AG: Ad-Hoc Captain America - EBITDA - adhoc - Börsennachrichten

EQSAdhoc Enapter AG Key word MiscellaneousMiscellaneous Enapter AG AdHoc Captain America EBITDA 28Dec2023 1740 CETCEST Disclosure of an inside information acc to Article 17 MAR of the Regulation No 5

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA - adhoc - Börsennachrichten - Vimarsana News

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA - adhoc - Börsennachrichten

Kuros Biosciences AG Key word StudyStudy results Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials STRUCTURE and MAXA 27Dec2023 0700 CETCEST Release of an ad hoc ann

CREALOGIX publishes interim financial statements for the first quarter of the financial year 2023/24 - adhoc - Börsennachrichten - Vimarsana News

CREALOGIX publishes interim financial statements for the first quarter of the financial year 2023/24 - adhoc - Börsennachrichten

Crealogix Holding AG Key word Quarterly Interim Statement CREALOGIX publishes interim financial statements for the first quarter of the financial year 202324 27Dec2023 0700 CETCEST Release of an ad h

Related Topics:
United StatesSwiss Exchange